SCHEMBL14807614

SCHEMBL14807614

Cc1ccc(C(=O)NC(=S)Nc2ccc(F)c(F)c2F)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.62
▸ RAB9A P51151 5/20 0.60
▸ NPC1 O15118 4/20 0.60
▸ NPSR1 Q6W5P4 2/20 0.60
▸ L3MBTL1 Q9Y468 1/20 0.60
▸ ALDH1A1 P00352 8/20 0.57
▸ MAPT P10636 6/20 0.57
▸ KMT2A Q03164 5/20 0.57
▸ ALOX12 P18054 4/20 0.57
▸ LMNA P02545 1/20 0.57
▸ KDM4E B2RXH2 1/20 0.57
▸ CYP1A2 P05177 1/20 0.54
▸ SMN1; SMN2 Q16637 5/20 0.53
▸ GAA P10253 1/20 0.53
▸ MEN1 O00255 3/20 0.51
▸ TDP1 Q9NUW8 1/20 0.51
▸ CYP2C9 P11712 2/20 0.51
▸ HTT P42858 2/20 0.51
▸ CYP3A4 P08684 1/20 0.51
▸ CYP2C19 P33261 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5451832 0.78 ALDH1A1 (0.80) RAB9ANPC1NPSR1L3MBTL1ALDH1A1
SCHEMBL3025853 0.77 EPHX1 (0.45) RAB9ANPC1ALDH1A1KMT2ALMNA
SCHEMBL8708055 0.77 ALDH1A1 (0.73) POLBRAB9ANPC1NPSR1L3MBTL1
SCHEMBL14808249 0.76 MAPT (0.62) POLBRAB9ANPC1NPSR1L3MBTL1
SCHEMBL14096476 0.75 RAB9A (1.00) POLBRAB9ANPC1NPSR1L3MBTL1
SCHEMBL5458088 0.75 KMT2A (0.70) RAB9ANPC1NPSR1ALDH1A1MAPT
SCHEMBL10712606 0.75 ALDH1A1 (0.63) POLBNPSR1ALDH1A1MAPTKMT2A
SCHEMBL34471242 0.74 EPHX1 (0.60) RAB9ANPC1NPSR1L3MBTL1ALDH1A1
SCHEMBL9728573 0.74 ALDH1A1 (0.60) POLBRAB9ANPC1NPSR1L3MBTL1
SCHEMBL14096651 0.73 KCNMA1 (0.75) RAB9ANPC1NPSR1L3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150011528-A1 PHENYLIMIDE-CONTAINING BENZOTHIAZOLE DERIVATIVE OF ITS SALT AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME YUHAN CORPORATION (KR) 2015-01-08 — — US disclosed
EP-2758384-A1 PHENYLIMIDE-CONTAINING BENZOTHIAZOLE DERIVATIVE OR ITS SALT AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME Yuhan Corporation (KR) 2014-07-30 — — EP disclosed
WO-2013043001-A1 PHENYLIMIDE-CONTAINING BENZOTHIAZOLE DERIVATIVE OR ITS SALT AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME YUHAN CORPORATION (KR) 2013-03-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150011528-A1 PHENYLIMIDE-CONTAINING BENZOTHIAZOLE DERIVATIVE OF ITS SALT AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME ILK, PKMYT1, PLAUR POLB 4153/4885RAB9A 916/4885NPC1 1984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback